AstraZeneca’s Dapagliflozin gets marketing authorisation for chronic kidney disease in India AstraZeneca India has received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the treatment of…
AstraZeneca’s Dapagliflozin (Forxiga) gets marketing authorisation in India The drug will be used to treat patients with heart failure AstraZeneca Pharma India (AstraZeneca India), received the…
